M Assayag
Impact in
- Nephrology top 10%
- Chronic Kidney Disease and Diabetes
-
- Diabetes, Cardiovascular Risks, and Lipoproteins
- Pituitary Gland Disorders and Treatments
Papers in
-
- Diabetes, Cardiovascular Risks, and Lipoproteins 2
- Pituitary Gland Disorders and Treatments 2
M Assayag
9 papers receiving 226 citations
Peers
Comparison fields: 5 of 47
- Nephrology 50
- Endocrinology, Diabetes and Metabolism 87
- Clinical Biochemistry 27
- Biochemistry 21
- Otorhinolaryngology 13
Countries citing papers authored by M Assayag
This map shows the geographic impact of M Assayag's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M Assayag with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M Assayag more than expected).
Fields of papers citing papers by M Assayag
This network shows the impact of papers produced by M Assayag. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M Assayag. The network helps show where M Assayag may publish in the future.
Co-authors
The 25 scholars most cited alongside M Assayag, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 1998 | 17 | |
| 2 | 1998 | 5 | |
| 3 | 1998 | 47 | |
| 4 | 1998 | 23 | |
| 5 | Diabetes: from phenotypes to genotypes. | 1997 | 16 |
| 6 | 1996 | 0 | |
| 7 | Variable efficacy of octreotide in diabetic diarrhea. | 1996 | 1 |
| 8 | Microalbuminuria in obese patients with or without hypertension. | 1996 | 85 |
| 9 | 1995 | 39 | |
| 10 | 1995 | 7 |
About M Assayag
M Assayag is a scholar working on Endocrinology, Diabetes and Metabolism, Otorhinolaryngology, Ophthalmology, Biochemistry and Clinical Biochemistry, having authored 10 papers that have together received 240 indexed citations. Recurring topics across this work include Diabetes, Cardiovascular Risks, and Lipoproteins (2 papers), Pituitary Gland Disorders and Treatments (2 papers), Cancer, Hypoxia, and Metabolism (2 papers), Retinal Diseases and Treatments (2 papers), Head and Neck Surgical Oncology (1 paper), Hypothalamic control of reproductive hormones (1 paper), Retinal Imaging and Analysis (1 paper) and Diet and metabolism studies (1 paper). The work is most often cited by research in Nephrology (50 citations), Endocrinology, Diabetes and Metabolism (87 citations), Clinical Biochemistry (27 citations), Biochemistry (21 citations) and Otorhinolaryngology (13 citations). M Assayag has collaborated with scholars based in France. Frequent co-authors include JR Attali, Paul Valensi, J. Pariès, B. Lormeau, A Warnet, P J Guillausseau, Marie Virally, J Lubetzki, Marie‐Aline Charles and Jacqueline Peynet. Their work appears in journals such as Diabetic Medicine, Annals of Otology Rhinology & Laryngology, The Journal of Clinical Endocrinology & Metabolism, Clinical Endocrinology and Clinica Chimica Acta.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.